document: rounds of 2Gy X-ray irradiation or two doses of TrQβ@b-3WJsiEGFR Let-7g via CED infusion all developed significantly smaller brain tumours (56.0 ± 22.7 mm3 for X-ray irradiation only and 67.7 ± 20.7 mm3 for TrQβ@b-3WJsiEGFR Let-7g only on Day 34) than the control and TrQβ VLPs-treated groups, recurrence was observed after 34 days of treatment (127.5 ± 45.8 mm3 for X-ray irradiation only and 177.3 ± 25.7 mm3 for TrQβ@b-3WJsiEGFR Let-7g only on Day 41). No obvious improvement in survival rate was